Annual Shareholders Equity
$503.35 M
+$503.35 M+100.00%
December 31, 2023
Summary
- As of February 7, 2025, APGE annual stockholders equity is $503.35 million, with the most recent change of +$503.35 million (+100.00%) on December 31, 2023.
- During the last 3 years, APGE annual shareholders equity has risen by +$503.35 million (+100.00%).
- APGE annual shareholders equity is now at all-time high.
Performance
APGE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$734.40 M
-$39.24 M-5.07%
September 30, 2024
Summary
- As of February 7, 2025, APGE quarterly stockholders equity is $734.40 million, with the most recent change of -$39.24 million (-5.07%) on September 30, 2024.
- Over the past year, APGE quarterly shareholders equity has increased by +$231.05 million (+45.90%).
- APGE quarterly shareholders equity is now -23.29% below its all-time high of $957.34 million, reached on March 31, 2024.
Performance
APGE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
APGE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +45.9% |
| 3 y3 years | +100.0% | +100.0% |
| 5 y5 years | +100.0% | +100.0% |
APGE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -23.3% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -23.3% | -100.0% |
| alltime | all time | at high | -100.0% | -23.3% | -100.0% |
Apogee Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $734.40 M(-5.1%) |
| Jun 2024 | - | $773.64 M(-19.2%) |
| Mar 2024 | - | $957.34 M(+90.2%) |
| Dec 2023 | $503.35 M | $503.35 M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $501.28 M(>+9900.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00 | $0.00 |
FAQ
- What is Apogee Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Apogee Therapeutics?
- What is Apogee Therapeutics annual shareholders equity year-on-year change?
- What is Apogee Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly shareholders equity year-on-year change?
What is Apogee Therapeutics annual stockholders equity?
The current annual shareholders equity of APGE is $503.35 M
What is the all time high annual shareholders equity for Apogee Therapeutics?
Apogee Therapeutics all-time high annual stockholders equity is $503.35 M
What is Apogee Therapeutics annual shareholders equity year-on-year change?
Over the past year, APGE annual stockholders equity has changed by +$503.35 M (+100.00%)
What is Apogee Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of APGE is $734.40 M
What is the all time high quarterly shareholders equity for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly stockholders equity is $957.34 M
What is Apogee Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, APGE quarterly stockholders equity has changed by +$231.05 M (+45.90%)